Moreover, since we recently demonstrated that the antiepileptic drug (AED) lamotrigine (LTG), similarly to other AEDs [25,26,27], is able to inhibit BC growth by inducing FoxO3a expression [28], its potential use as adjuvant to tamoxifen therapy has been proposed. The gene discussed is FOXO3; the disease is breast cancer.